distillation №14
— — —
3D structure
// no structure on file
pdb file not produced for this fold
// powered by Mol* — drag to rotate · scroll to zoom · use the right panel for cartoon / spacefill / surface presets, measurements & export
AI analysis
tldr
—
detailed analysis
—
research data
known activity
// not yet provided by clinical agent
biohacker use
// not yet provided by clinical agent
mechanism class
// not yet provided by clinical agent
folding metrics
// no per-residue pLDDT trace — Boltz-2 returned summary metrics only
confidence metrics
domain annotations
// not yet annotated by clinical / structural agents
peptide profile
These are sequence-based heuristic estimates, not wet-lab measurements. Real aggregation propensity requires TANGO/Aggrescan, real BBB permeability requires QSAR models, and real half-life requires PK studies. Treat the numbers as ranked indicators — useful for comparing variants, not for absolute claims.
known binders
// no ChEMBL binders found for this target
agent findings
caveats
- ─in silico prediction only — requires wet lab validation
- ─single-run prediction (not ensembled)
- ─predicted properties may not reflect biological reality
- ─this is research, not medical advice
- ─modified peptides have not been synthesized or tested